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Microcystin-LR is a cyclic peptide released 
by several bloom-forming toxic cyano-
bacteria (Carmichael and Falconer 1993). 
Understanding the toxicity of microcystin-LR 
is of paramount importance because of both 
the potency of its acute cyto  toxicity and its 
tumor-promoting activity in hepato  cytes of 
animals and humans (Dietrich and Hoeger 
2005; Gehringer 2004). Microcystin-LR tox-
icity is primarily caused by inhibition of the 
serine/threonine protein phosphatases PP1 
and PP2A, thereby influencing the regulation 
of the balance between cellular protein phos-
phorylation and dephosphorylation (Dietrich 
and Hoeger 2005; Gehringer 2004). Several 
PP1 and PP2A inhibitors, such as okadaic 
acid, nodularin, and microcystin-LR, are 
classified as tumor promoters (Fujiki and 
Suganuma 1999). Several epidemiological 
studies have indicated that consumption of 
cyanobacteria-contaminated water can favor 
the growth of human hepato  cellular carcinoma 
(Falconer and Humpage 2005; Ueno et al. 
1996; Yuan et al. 2006). Microcystin-LR has 
poor cell membrane permeability except for 
the membranes of hepato  cytes (Chong et al. 
2000; Eriksson et al. 1990; Nong et al. 2007; 
Runnegar et al. 1995). Recently, we (Komatsu 
et al. 2007) and others (Fischer et al. 2005; 
Monks et al. 2007) reported that the expres-
sion of the human hepato  cyte uptake trans-
porter OATP1B1 or OATP1B3 was critical 
for the selective uptake of microcystin-LR into 
hepatocytes and for induction of its fatal cyto-
toxicity. However, the intra  cellular regulatory 
mechanisms that determine whether a cell will 
die or survive in response to microcystin-LR 
have not been clarified.
The molecular basis of the tumor-promoting   
ability of microcystin-LR is unclear but most 
likely involves protein phosphatase inhibition 
leading to hyperphosphorylation of many 
cellu  lar proteins and, consequently, destruc-
tion of cell-cycle control (Fujiki and Suganuma 
1999; Guy et al. 1992; Messner et al. 2006). 
Several signaling pathways have been impli-
cated in cellu  lar effects of microcystin- 
LR. Previous studies have demonstrated that 
microcystin-LR can stabilize Xenopus and 
zebrafish β-catenin protein levels by suppress-
ing glycogen synthase kinase-3β (GSK-3β), 
a serine/threonine protein kinase that phos-
phorylates β-catenin, resulting in its protea-
somal degradation (Li et al. 2001; Wang et al. 
2005). β-Catenin is a multi  functional pro-
tein that plays an important role in the trans-
duction of wingless int (Wnt) signals, which 
contributes to hyperplasia and tumorigenic 
progression, and in cellular adhesion by link-
ing the cytoplasmic domains of cadherin to 
each other (Grimes and Jope 2001; Olmeda 
et al. 2003; Orford et al. 1999; Wang et al. 
2005). In general, a low cyto  plasmic level of 
β-catenin is maintained through inter  action 
with a protein complex consisting of adenoma-
tous polyposis coli, Axin, PP2A, and GSK-3β 
(Ding et al. 2000). Recently, p53 has been 
reported to induce proteasomal degradation 
of β-catenin through the transactivation of 
seven in absentia homolog 1 (siah-1), which 
encodes an E3 ubiquitin ligase (Jang et al. 
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Ba c k g r o u n d: Microcystin-LR, a cyclic hepta  peptide, possesses the ability to inhibit the serine/
threonine protein phosphatases PP1 and PP2A and, consequently, exhibits acute hepato  cytotoxicity. 
Moreover, microcystin-LR induces cellular proliferation, resulting in tumor-promoting activity in 
hepato  cytes. However, mechanisms that regulate the balance between cell death and proliferation 
after microcystin-LR treatment remain unclear.
oB j e c t i v e: We examined the contribution of the transcription factor p53, as well as that of 
the hepatic uptake transporter for microcystin-LR, organic anion transporting poly  peptide 1B3 
(OATP1B3), to the cellular response to microcystin-LR exposure.
Me t h o d s : We analyzed intracellular signaling responses to microcystin-LR by immunoblotting and 
real-time reverse-transcriptase polymerase chain reaction techniques using HEK293 human embry-
onic kidney cells stably transfected with SLCO1B3 (HEK293-OATP1B3). In addition, we analyzed 
the effect of attenuation of p53 function, via the p53 inhibitor pifithrin-α, and knockdown of p53 
mRNA on the cyto  toxicity of microcystin-LR using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) assay.
re s u l t s: Microcystin-LR induced the phosphorylation and accumulation of p53 in HEK293-
OATP1B3 cells, which resulted in up-regulation of the expression of p53 transcript targets, 
including p21 and seven in absentia homolog 1 (siah‑1). In addition, microcystin-LR activated 
Akt signaling through the phosphorylation of Akt and glycogen synthase kinase 3β. Although Akt 
signaling was activated, the accumulation of p53 led cells to apoptosis after treatment with 50 nM 
microcystin-LR for 24 hr. Both pharmacological inhibition of transcription factor activity of p53 
by pifithrin-α and knockdown of p53 with small hairpin RNA attenuated the susceptibility of 
HEK293-OATP1B3 cells to microcystin-LR.
co n c l u s i o n s: This study demonstrates the importance of p53 in the regulation of cell fate after 
exposure to microcystin-LR. Our results suggest that, under conditions of p53 inactivation (includ-
ing p53 mutation), chronic exposure to low doses of microcystin-LR may lead to cell proliferation 
through activation of Akt signaling. Results of this study may contribute to the develop  ment of 
chemo  prevention and chemotherapeutic approaches to microcystin-LR poisoning.
key w o r d s : Akt, apoptosis, β-catenin, cyclin D1, GSK-3β, microcystin-LR, OATP1B3, p53, 
proliferation, siah-1. Environ Health Perspect 118:1292–1298 (2010).  doi:10.1289/ehp.1001899 
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2005; Jung et al. 2007; Kim et al. 2004; Park 
et al. 2006). Accumulation of β-catenin can 
induce the expression of various genes, such 
as cyclin D1 and c-myc, which promote cell 
prolifera  tion and transformation of many cell 
types (Seki et al. 2006). Phosphorylation of 
GSK-3β at Ser9, which results in an inactive 
form of GSK-3β, is mediated by activated 
Akt, which is a serine/threonine protein kinase 
that is a well-established anti  apoptotic pro-
tein (Frame and Cohen 2001; Grimes and 
Jope 2001). Akt regulates many cellular pro-
cesses implicated in tumori  genesis (Altomare 
and Testa 2005; Lu et al. 2007). Recently, 
constitutive activation of Akt was reported in 
microcystin-transformed immortalized colo-
rectal crypt cells (Zhu et al. 2005). We also 
recently reported that microcystin-LR induces 
apoptosis through activation of mitogen- 
activated protein kinase (MAPK) (Komatsu 
et al. 2007). Moreover, there is increasing evi-
dence of a functional relationship between p53 
and MAPK. Thus, MAPK that is phospho-
rylated after exposure to cellular stress then 
phosphorylates p53 and, consequently, induces 
apoptosis (Guan et al. 2008; Karunakaran et al. 
2008; Liu et al. 2009; Shimada et al. 2003).
p53 functions as a transcription factor 
that, in response to a variety of cellu  lar stresses, 
including DNA damage and hypoxia, regulates 
its downstream genes and p53-mediated path-
ways in an attempt to repair DNA damage 
through induction of cell-cycle arrest. p53 is 
involved in G1 and G2 cell-cycle arrest through 
activation of the p21 cyclin-dependent kinase 
inhibitor (Burns and El-Deiry 1999).
In the present study, we used wild-type 
p53-expressing HEK293 human embryonic 
kidney cells stably transfected with OATP1B3, 
to demon  strate that a lethal concentration of 
microcystin-LR stimulated not only cellular 
signal transduction, leading to cell death, but 
also cell survival signals. These data suggest 
that if cell damage inflicted by microcystin-LR 
cannot be repaired, then p53 probably pro-
motes cell apoptosis. However, if p53 is inac-
tivated, chronic exposure to a low dose of 
microcystin-LR might lead to cell proliferation 
through activation of Akt signaling.
Materials and Methods
Reagents and antibodies. Reagents and anti-
bodies used are described in the Supplemental 
Material (doi:10.1289/ehp.1001899).
Cell culture. Wild-type HEK293 cells were 
stably transfected with the plasmids pcDNA3.1-
SLCO1B3 (HEK293-OATP1B3 cells) or 
pcDNA3.1-control vector (HEK293-CV cells), 
which were generated previously (König et al. 
2000; Letschert et al. 2004). Cells were cul-
tured in Minimum Essential Medium (MEM; 
Sigma Chemical Co., St. Louis, MO, USA) 
supplemented with 10% fetal calf serum (FCS), 
100 U/mL penicillin, 100 µg/mL strepto  mycin 
(MEM/10% FCS) and 400 µg/mL G418 at 
37°C, 100% humidity, and 5% CO2. 
Preparation of nuclear fractions. Cells 
were resuspended in buffer A (10 mM Tris-Cl, 
pH 8.0, 10 mM KCl, 1.5 mM MgCl2, 60 µM 
phenylmethylsulfonyl fluoride, and a protei-
nase inhibitor cocktail) at 4°C, incubated for 
20 min on ice, and homogenized for 30 sec. 
The homogenate was centrifuged at 3,000 × g 
for 5 min, and the post  nuclear supernatant 
was clarified by centrifugation for 30 min at 
15,000 × g. The first pellet was washed twice 
with buffer A and resuspended in buffer A con-
taining 1% Nonidet P-40, and this suspension 
was homogenized for 30 sec. Homogenates 
were collected by centrifugation for 30 min at 
15,000 × g, and supernatants were collected as 
the nuclear fraction. Prepared nuclear fractions 
were analyzed by immunoblotting as previously 
described (Komatsu et al. 2000, 2007). For 
details of immuno  blotting, see Supplemental 
Material (doi:10.1289/ehp.1001899).
Immunoprecipitation. After incubation 
with microcystin-LR, cells were lysed with Lysis 
buffer (10 mM Tris-HCl, pH 8.0, 10 mM 
KCl, 1 mM EDTA, 1% Nonidet P-40, 1% 
protein inhibitor cocktail,and 1 mM NaF). 
Following homogenization, the lysates were 
centrifuged at 10,000 × g for 30 min at 4°C. 
One milliliter of cell lysate was incubated over-
night at 4°C with 5 µL of agarose-conjugated 
anti-p53 antibody. The pellet was washed four 
times with Lysis buffer and then suspended 
in SDS-polyacrylamide gel Laemmli sample 
buffer. After SDS/PAGE and immunoblotting 
with the respective phospho-p53 antibodies, 
phosphorylation of p53 at Ser6, Ser9, Ser15, 
Ser20, Ser37, Ser46, and Ser392 was analyzed in 
the same samples. After stripping with strip-
ping buffer (0.5 M Tris-Cl, pH 6.8 containing 
1% 2-ME) for 30 min at 50˚C, the blots were 
reprobed with an anti-p53 antibody.
Detection of ubiquitination. HEK293-
OATP1B3 cells were treated with 50 nM 
microcystin-LR for 12 hr under serum-free 
conditions. The cells were treated with 10 µM 
lactacystin for 2 hr before cell harvest to 
inhibit proteasomal degradation of β-catenin. 
Whole-cell lysates from harvested cells were 
then analyzed by immuno  blot analy  sis.
Real‑time reverse‑transcriptase polymerase 
chain reaction (RT‑PCR). Total cellular RNA 
was extracted from HEK293-OATP1B3 
cells using TRIzol (Invitrogen, Carlsbad, 
CA, USA) according to the manu  facturer’s 
instructions. cDNA was synthesized by reverse 
transcription of total RNA using reverse tran-
scriptase (Toyobo, Osaka, Japan) and an 
oligo(dT)20 primer (Toyobo). The result-
ing cDNA was amplified using the following 
three PCR steps: preincubation at 95°C for 
10 min, 45 cycles of denaturation at 95°C for 
15 sec and then annealing at 56°C for 30 sec, 
and finally extension at 72°C for 30 sec, using 
FastStart Universal SYBR Green Master 
(Roche, Basel, Switzerland). The fluorescent 
signal from the samples was acquired at the 
end of the elongation step. Real-time PCR 
was performed using the Thermal Cycler Dice 
Real Time System (Takara, Otsu, Japan). 
The following sense and antisense primers,   
respectively, were used for PCR: siah-1, 
5´-GACTGGCACAACTGCATCCA-3´ 
and 5´-AGCCAAGTGCGAATGGATC-3´; 
cyclin D1, 5´-AATGACCCCGCACG 
ATT-3´ and 5´-GCACAGAGGGCAAC 
GAAGG-3´; c-myc, 5´-TGCTGCCAA 
GAGGGTCAAG-3´ and 5´-GCCTCCAA 
GACGTTGTGAGT-3´; glyceraldehyde 
3-phosphate dehydrogenase (GAPDH), 
5´-TGGACCTGACCTGCCGTCTA-3´ and 
5´-CCCTGTTGCTGTAGCCAAA  TTC-3´. 
For each sample, the relative expression level 
was calculated using cycle time (Ct) values, 
which were normalized against GAPDH. 
Relative quantification (fold change) between 
different samples was then determined 
according to the 2–ΔΔCt method (Livak and 
Schmittgen 2001).
Pifithrin‑α treatment. HEK293-OATP1B3 
cells in 170 µL MEM were pretreated without 
(6% DMSO vehicle control) or with 10 µL 
pifithrin-α (30 µM) for 5 hr and were then 
incubated for 3 days with 20 µL of micro-
cystin-LR. After incubation, micro  cystin-LR 
cyto  toxicity was analyzed by analysis of cell 
survival using the 3-(4,5-dimethyl  thiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) 
assay [see Supplemental Material (doi:10.1289/
ehp.1001899) for details].
Knockdown of p53 mRNA. HEK293-
OATP1B3 cells were transiently transfected 
with the small hairpin RNA (shRNA) plas-
mid pSuppressorNeo p53 using Lipofectamine 
2000 (Invitrogen) according to the manu-
facturer’s protocol to generate p53 small 
inter  fering RNA (siRNA). Cells were then 
incubated for 72 hr. To determine p53 expres-
sion by immuno  blotting, 4 × 106 cells in 
10 mL MEM/10% FCS were inoculated into 
100-mm dishes. After 24 hr, the cells were 
harvested and the cell lysates were analyzed. 
For MTT analysis, exponentially growing 
transfected HEK293-OATP1B3 cells were 
trypsinized and harvested, and equal numbers 
of cells (1.6 × 104) in 180 µL MEM/10% FCS 
were then inoculated into each well of a 96-well 
micro  plate and assayed using the MTT assay. 
Statistical analysis. Differences between 
groups were analyzed using Wilcoxon–Mann–
Whitney test. p-Values < 0.05 were considered 
significant. 
Results
Activation of the p53 pathway by micro‑
cystin‑LR. HEK293-OATP1B3, but not 
HEK293-CV, cells were sensitive to micro-
cystin-LR [see Supplemental Material, Takumi et al.
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To determine if p53 is involved in micro-
cystin-LR–induced apoptosis, we examined 
p53 protein stability and its phosphorylation 
in HEK293-OATP1B3 cells by immuno-
blot analysis (Figures 1 and 2). The level of 
p53 protein increased after 3.5 hr of expo-
sure to a lethal concentration (50 nM) of 
micro  cystin-LR (Figure 1). After accumula-
tion of p53, the expression level of protein 
product of its transcriptional target gene p21 
also increased (Figure 1). After 3.5–5 hr, we 
observed phosphorylation of p53 at Ser15, 
which reduces the ability of p53 to bind 
to its negative regulator, the oncoprotein 
MDM2, and at Ser392, which is increased in 
human tumors. In both cases phosphoryla-
tion coincided with the accumulation of p53 
protein (Figure 2). After these early phospho-
rylation events, we observed delayed phos-
phorylation of p53 at Ser37, which impairs 
the ability of MDM2 to bind p53, thus pro-
moting both the accumulation and activa-
tion of p53 in response to DNA damage, 
and at Ser46, which is important in regulat-
ing the ability of p53 to induce apoptosis. 
Phosphorylation was slightly detectable at 
these sites after 3.5 and 5 hr but was consid-
erably stronger after 8–10 hr of exposure to 
50 nM microcystin-LR (Figure 2). In addi-
tion, we observed weak phosphorylation of 
p53 at Ser6 and Ser9, which are mediated by 
the casein kinases CK1δ and CK1ε, and at 
Ser20, which is induced by DNA damage and 
leads to reduced interaction between p53 and 
MDM2, as reflected by accumulation of p53 
protein (Figure 2).
Activation of the Akt pathway by micro‑
cystin‑LR. Substrates of PP2A, a target of 
microcystin-LR, include components of the 
well-described Akt cell survival signaling 
pathway. We therefore analyzed the effect 
of microcystin-LR on the activation of such 
components, including 3-phospho  inositide–
dependent protein kinase 1 (PDK1), Akt, and 
GSK-3β. The intensity of PDK1 phosphory-
lation at Ser241, which correlates with PDK1 
activity, was slightly and transiently increased 
3–6 hr after exposure to microcystin-LR and 
recovered to control levels after 10 hr. In 
contrast, phosphorylation of Akt at the activat-
ing phosphorylation sites Ser473 and Thr308 
was considerably enhanced by exposure of the 
cells to 50 nM micro  cystin-LR. However, the 
expression level of Akt in HEK293-OATP1B3 
cells was not changed by treatment with 50 nM 
micro  cystin-LR for up to 10 hr (Figure 3).
In HEK293-OATP1B3 cells, phospho-
rylation of GSK-3β increased in a time- 
dependent manner after incubation with 
50 nM microcystin-LR for up to 10 hr. In 
contrast, the expression level of GSK-3β did 
not change (Figure 4A). These data suggest 
that microcystin-LR indirectly regulates the 
activity of both Akt and GSK-3β.
Correlation of β‑catenin with micro‑
cystin‑LR cytotoxicity. We next determined 
if microcystin-LR–induced phosphorylation 
of GSK-3β led to an enhanced nuclear trans-
location of its substrate protein β-catenin. 
Surprisingly, the level of β-catenin in the 
nuclear fraction of cells after up to 24 hr incu-
bation with 50 nM micro  cystin-LR indicated 
that β-catenin levels in the nucleus were equiva-
lent before and after treatment (Figure 4B). 
In addition, we detected ubiquitina  tion of 
β-catenin in the presence of 10 µM protea-
some inhibitor lactacystin after treatment with 
micro  cystin-LR (Figure 4C).
Analysis of cyclin D1 and c-myc mRNA 
expression. To confirm that β-catenin levels 
in the nucleus were not increased after micro-
cystin-LR treatment, we analyzed the mRNA 
Figure 3. Microcystin‑LR activates the Akt signal‑
ing pathway in HEK293‑OATP1B3 cells. Cell lysates 
of HEK293‑OATP1B3 cells treated with 50 nM 
microcystin‑LR for the indicated times were ana‑
lyzed by immuno  blotting using anti‑phosphorylated 
PDK1 (p‑PDK1) and anti‑phosphorylated phosphAkt 
(p‑Akt) antibodies. The blots were reprobed with 
antibodies against the Akt protein; β‑actin was used 
as an internal control. Results are representative of 
three independent experiments.
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Figure 4. Correlation between phosphorylation of 
GSK‑3β and nuclear accumulation of β‑catenin in 
HEK293‑OATP1B3 cells after treatment with 50 nM 
microcystin‑LR. (A) Immunoblot analysis of phos‑
phorylated (p‑)GSK‑3β (Ser9). Blots were reprobed 
with an anti‑GSK‑3β antibody; α‑tubulin was used 
as an internal control. (B) Immunoblot analysis of 
β‑catenin accumulated in the nuclear fraction of 
HEK293‑OATP1B3 cells. The blots were reprobed 
with an antibody against lamin B, which was 
used as an internal control for the nuclear frac‑
tion. (C) Immunoblot analysis of β‑catenin in whole 
HEK293‑OATP1B3 cells analyzed by immunoblot 
analysis. The results are representative of three 
independent experiments.
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Lamin B
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Figure 2. Site‑selective phosphorylation of p53 
by microcystin‑LR cell treatment. Cell lysates of 
HEK293‑OATP1B3 cells treated with 50 nM micro‑
cystin‑LR for the indicated times were immuno‑
precipitated with agarose‑conjugated anti‑p53 
antibodies. The pellet was analyzed by immuno‑
blotting using antibodies against specific phos‑
phorylated sites in p53 (p‑p53), and the blots were 
reprobed with an anti‑p53 phosphorylation site–
independent antibody. Results are representative 
of three independent experiments.
11 5810 
p–p53 (Ser6)
p–p53 (Ser9)
p–p53 (Ser15)
p–p53 (Ser20)
p–p53 (Ser37)
p–p53 (Ser46)
p–p53 (Ser392)
p53
p53
p53
p53
p53
p53
p53
Control
Microcystin-LR
3.5 Incubation time (hr)
Figure 1. Microcystin‑LR treatment of HEK293‑
OATP1B3 cells activates the p53 signaling pathway. 
HEK293‑OATP1B3 cells were incubated without 
(control) or with 50 nM microcystin‑LR for the indi‑
cated times. Cell lysates were then immuno  blotted 
for p53; for protein product of its transcriptional 
target, gene p21; or for α‑tubulin, which was used 
as an internal control. Results are representative of 
three independent experiments.
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levels of the β-catenin targets cyclin D1 and 
c-myc after treatment with 50 nM micro-
cystin-LR. The mRNA level of cyclin D1 was 
not changed after microcystin-LR treatment, 
but, unexpectedly, that of c-myc was consider-
ably up-regulated (Figure 5A), suggesting that 
microcystin-LR activated c-myc through sig-
naling pathways other than β-catenin.
Induction of siah‑1 by microcystin‑LR. 
The lack of an increase in nuclear levels of 
β-catenin despite the fact that GSK-3β was 
phosphorylated after microcystin-LR treatment 
suggested that β-catenin might be ubiquiti-
nated and degraded through another pathway 
that is activated by microcystin-LR. β-Catenin 
can be degraded after p53-dependent   
up-regulation of the E3 ubiquitin ligase gene 
siah-1 and its protein product. We therefore 
determined whether siah-1 mRNA levels 
were modulated after treatment of cells with 
50 nM microcystin-LR. Real-time RT-PCR 
analysis indicated that microcystin-LR treat-
ment led to the up-regulation of siah-1 
mRNA (Figure 5B), suggesting that siah-1-
–mediated degradation of β-catenin may be 
responsible for the lack of nuclear accumula-
tion of β-catenin.
Effects of p53 on the cytotoxicity of micro‑
cystin‑LR. To verify whether p53 was critically 
important for microcystin-LR–induced apop-
tosis, we analyzed the effect of pretreatment 
with an inhibitor of the transcription factor 
activity of p53, pifithrin-α, for 5 hr on the 
cytotoxicity of micro  cystin-LR in HEK293-
OATP1B3 cells. Pifithrin-α concentration-
dependently attenuated the susceptibility of 
HEK293-OATP1B3 cells to microcystin-LR 
compared with vehicle (6%DMSO)-treated 
(control) cells (Figure 6). The median inhibi-
tory concentrations (IC50) were approximately 
2 and 8 times higher in cells that were pre-
treated with 10 µM and 30 µM pifithrin-α, 
respectively, than in controls. We further ana-
lyzed the acute cyto  toxicity of microcystin-LR 
in HEK293-OATP1B3 cells after knock-
down of p53 following transfection with a 
p53 shRNA plasmid. This plasmid effectively 
decreased the expression level of p53 protein 
(Figure 7A). The susceptibility of HEK293-
OATP1B3 cells to microcystin-LR was attenu-
ated to a greater extent by knockdown of p53 
than by transfection of cells with a plasmid 
encoding a scrambled shRNA sequence, which 
does not show significant homology to rat, 
mouse, or human gene sequences (Figure 7B).
Discussion
Microcystin-LR is of great interest because of 
its acute cytotoxicity and its tumor-promoting   
activity in hepato  cytes of animals and humans 
(Gehringer 2004; Li et al. 2009; Wang 
et al. 2005). In our previous studies aimed 
at clarifying the onset of liver-specific toxic-
ity of microcystin-LR (Komatsu et al. 2007; 
Nong et al. 2007), we demonstrated that 
transfection of OATP1B1 (SLCO1B1) or 
OATP1B3 (SLCO1B3) cDNA into HEK293 
cells increased their sensitivity to, and their 
accumulation of, microcystin-LR and, conse-
quently, induced apoptosis in those cells. The 
use of these cell lines permits exclusive analysis 
of the effects of low concentrations of micro-
cystin-LR on the cellular balance between 
phosphatase and kinase activity, which is a cru-
cial regulatory mechanism for cellular homeo-
stasis. PP2A is one of the key proteins in this 
regulatory mechanism (Junttila et al. 2008; 
Lin et al. 2007; Yan et al. 1997) and is known 
to be a target molecule of micro  cystin-LR 
(Gehringer 2004). However, because of 
the poor membrane permeability of micro-
cystin-LR, a complete understanding of the 
effect of low concentrations of microcystin-LR 
on various cell signaling pathways remains 
unclear. Here, we used HEK293-OATP1B3 
cells to clarify the molecular basis of the bal-
ance between cell death and cell survival after 
microcystin-LR treatment. In this study, we 
focused on the effects of low concentrations 
of microcystin-LR on the phosphorylation of 
p53 and on Akt signaling pathways.
In our previous study using HEK293-
OATP1B3 cells, microcystin-LR activated 
MAPKs, including ERK1/2 (extra  cellular 
signal-regulated kinase 1/2), JNK (c-Jun 
N-terminal kinase), and p38, through inhibi-
tion of PP2A (Komatsu et al. 2007). In the 
present study, we demonstrated that once 
MAPKs are activated by micro  cystin-LR, 
they activate downstream kinases that phos-
phorylate a number of substrates, including 
p53, which plays a central role in the cellul  ar 
response to various stresses (Wu 2004). 
Treatment with 50 nM microcystin-LR for 
Figure 5. Effect of 50 nM microcystin‑LR on the expression of cyclin D1, c-myc, and siah-1 mRNA in 
HEK293‑OATP1B3 cells. mRNA levels of cyclin D1 and c-myc (A) and of siah-1 (B) were quantified by real‑
time RT‑PCR, and the mRNA expression level of each sample was calculated relative to that of GAPDH, 
which was used as an internal control. The data represent mean ± SD of three independent experiments, 
each performed in triplicate.
*p < 0.05, and **p < 0.01, compared with control before incubation with microcystin‑LR.
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Figure 6. Effect of inhibition of transcription factor 
activity of p53 by pifithrin‑α on cell viability. Data 
represent mean ± SD of three independent experi‑
ments, each performed in triplicate. 
**p < 0.01, compared with control without pifithrin‑α 
treatment.
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Figure 7. Knockdown of p53 mRNA attenuated the 
susceptibility of HEK293‑OATP1B3 cells to micro‑
cystin‑LR cytotoxicity. Cells were transfected with 
the pSuppressorNeo p53 plasmid or the pSuppres‑
sorNeo control plasmid and incubated for 72 hr. 
(A) Immunoblot analysis of cells for p53 expres‑
sion using β‑actin as a loading control; results are 
representative of three independent experiments. 
(B) Viability of cells treated with microcystin‑LR for 
an additional 3 days and then analyzed using the 
MTT assay. Data represent mean ± SD of triplicate 
samples in each group.
**p < 0.01 compared with control cells transfected with 
control shRNA plasmid.
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10 hr induced phosphorylation of p53 at 
Ser15, Ser37, Ser46, and Ser392. In contrast, 
Ser6, Ser9, and Ser20 were weakly phosphory-
lated (Figure 2). The site at which p53 is phos-
phorylated is dependent on the kind of stress 
applied or the cell type assayed (Kurihara 
et al. 2007; Wu 2004). Phosphorylation of 
p53 at Ser15 promotes p53 stabilization by 
attenuating the inter  action between p53 and 
its negative regulator MDM2. The result-
ing accumulation of phosphorylated p53 
resulted in increased expression of p21 and 
siah-1 (Figures 1 and 5B). The p21 gene is 
a transcriptional target of p53 and induces 
inactivation of the cyclin-dependent kinase 
complex CDK2/cyclin E that controls the 
initiation of DNA synthesis (Hegarat et al. 
2005). Therefore, elevated levels of p53 and 
p21 after treatment with micro  ystin-LR are 
probably responsible for induction of cell-
  cycle arrest. These results are consistent with 
our previously reported flow cytometric analy-
sis, which revealed that the G1 phase, and the 
sub-G1 proportion of HEK293-OATP1B3 
cells, increased after exposure to 50 nM 
microcystin-LR for 24 hr (Komatsu et al. 
2007). Furthermore, the phosphorylation of 
p53 at Ser46 correlates well with the induc-
tion of apoptosis (Smith et al. 2003; Yoshida 
et al. 2006). Therefore, these events ultimately 
induce apoptosis of HEK293-OATP1B3 cells 
after exposure to microcystin-LR.
Recently, crosstalk between p53 and 
Akt has been hypothesized to play a critical 
role in the regulation of cell fate determi-
nation (Oren 2003), and the Akt signaling 
pathway plays an important role in promot-
ing cell proliferation (Lu et al. 2007). Zhu 
et al. (2005) reported that transformation of 
immortalized colo  rectal crypt cells by micro-
cystin is involved in the constitutive activation 
of Akt and MAPK. In the present study using 
HEK293-OATP1B3 cells, phosphorylation of 
Akt at Ser473 was enhanced after 3 hr incuba-
tion with 50 nM microcystin-LR (Figure 3). 
Subsequently, phosphorylation of Akt at 
Thr308 was gradually enhanced to reach a high 
level of phosphorylation (Figure 3). Therefore, 
microcystin-LR treatment may activate Akt 
to phosphorylate its downstream targets, such 
as GSK-3β kinase (Frame and Cohen 2001). 
Indeed, microcystin-LR induced the phos-
phorylation of GSK-3β at Ser9 (Figure 4A), 
resulting in a loss of GSK-3β kinase activity. 
Phosphorylation of Akt is regulated by the 
balance between the activities of PP2A and 
PDK1, which are upstream of Akt activation 
(Ivaska et al. 2002; Li et al. 2003). However, 
analysis of the phosphorylation level of PDK1 
indicated that it was slightly and transiently 
increased and subsequently recovered to con-
trol levels after treatment with microcystin-LR 
for 10 hr, suggesting that PDK1 may not play 
an important role in microcystin-LR-activation 
of Akt (Figure 3). In a previous study using 
unstimulated HEK293 cells, Casamayor et al. 
(1999) found that PDK1 was strongly phos-
phorylated at Ser241, which is critical for PDK1 
activity, and that the level of PDK1 phospho-
rylation at this site was unaffected by stimula-
tion with insulin-like growth factor-1. Hence, 
the phosphorylation of Akt observed in the 
present study is likely due to PP2A inhibition 
by microcystin-LR.
Because microcystin-LR can activate Akt 
to phosphorylate and thereby inhibit GSK-3β, 
we next analyzed the effect of incubation 
of HEK293-OATP1B3 cells with 50 nM 
microcystin-LR on the translocation of the 
GSK-3β substrate β-catenin from the cyto-
plasm to the nucleus. Inhibition of GSK-3β-
mediated phosphorylation of β-catenin plays 
a role in the translocation of β-catenin to the 
nucleus (Ding et al. 2000; Grimes and Jope 
2001). We therefore predicted that β-catenin 
might accumulate in the nucleus of HEK293-
OATP1B3 cells after incubation with 50 nM 
microcystin-LR. However, under these condi-
tions, nuclear accumulation of β-catenin was 
negligible (Figure 4B). In agreement with this 
finding, the transcription of cyclin D1—one of 
the transcriptional targets of β-catenin and a 
key regulator of cell-cycle progression (Alt et al. 
2000; Diehl et al. 1998; Seki et al. 2006)—was 
not enhanced by microcystin-LR (Figure 5A). 
We further analyzed the effect of micro-
cystin-LR on the mRNA level of c-myc, which 
is also a well-known transcriptional target of 
β-catenin. In contrast to the lack of effect of 
micro  cystin-LR on cyclin D1 expression levels, 
microcystin-LR strongly up-regulated c-myc 
mRNA (Figure 5A). A significant increase of 
c-myc may play a role in cellular accumulation 
of p53 (Matsumura et al. 2003). However, 
the c-myc promoter is targeted not only by 
β-catenin but also by other transcription fac-
tors under the control of multiple signal trans-
duction cascades, including the MAPK cascade 
(Vervoorts et al. 2006). Therefore, analysis of 
the mechanism by which c-myc transcription is 
enhanced remains to be investigated.
Nuclear accumulation of β-catenin is highly 
related to tumor promotion (Cui et al. 2001, 
2003), and PP2A activity also correlates with 
β-catenin degradation (Bos et al. 2006; Li et al. 
2001). The nuclear dephosphorylated β-catenin 
level is decreased after treatment with okadaic 
acid compared with control without okadaic 
acid (Bordonaro et al. 2007). To resolve the 
lack of correlation between the inactiva  tion 
of GSK-3β and the cellular β-catenin level 
after exposure to microcystin-LR, we consid-
ered the possibility that β-catenin might be 
degraded via the p53–siah-1 pathway after 
micro  cystin-LR treatment. Indeed, we detected 
ubiquitination of β-catenin after treatment 
with microcystin-LR (Figure 4C). According 
to previous studies, stabilization of p53 can 
Figure 8. Model of the p53‑Akt cross‑regulatory network that mediates the cellular response to micro‑
cystin‑LR stress in HEK293‑OATP1B3 cells. Microcystin‑LR simultaneously induces activation of both Akt 
and p53 signaling. However, p53 signaling is more active than Akt signaling in HEK293‑OATP1B3 cells after 
treatment with 50 nM microcystin‑LR. As a result, p53 induces arrest of the cell cycle and apoptosis by the 
induction of several genes, including p21 and siah-1. Abbreviations: P, phosphorylation; Ub, ubiquitination. 
Dashed lines indicate proposed pathways; small arrows, transport; large arrows, activation; blunt‑end 
lines (⊥), inhibition. Up (↑) and down (↓) arrows adjacent to protein names indicate activation and inactiva‑
tion, respectively. Proteins shaded gray were analyzed in the present study and/or in our previous studies 
(Komatsu et al. 2007).
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induce GSK-3β–independent proteasomal 
degradation of β-catenin through the trans-
activation of the E3 ubiquitin ligase siah-1, 
which is a transcriptional target gene of p53 
(Jang et al. 2005; Jung et al. 2007; Kim et al. 
2004; Park et al. 2006). Real-time RT-PCR 
analysis indicated that siah-1 mRNA signifi-
cantly increased in a time-dependent manner 
after exposure to microcystin-LR and that this 
increase coincided with the accumulation of 
p53 (Figure 5B). These results suggest that the 
p53–siah-1 pathway may play an important 
role in preventing microcystin-LR–induced 
β-catenin accumulation and may therefore 
block cell-cycle progression in HEK293-
OATP1B3 cells. In this scenario, if p53 were 
to be inactivated by, for example, a mutagen 
such as aflatoxin B1 (Szymańska et al. 2009) 
or by oxidative stress produced by microcystin- 
LR itself (Nong et al. 2007), chronic expo-
sure to low-dose micro  cystin-LR might lead 
to cell proliferation through activation of Akt 
  signaling.
To verify that p53 is critically related to 
microcystin-LR–induced apoptosis, we ana-
lyzed the cytotoxicity of microcystin-LR in 
HEK293-OATP1B3 cells in which p53 was 
inhibited or down-regulated. Both pharma-
cological inhibition of transcription factor 
activity of p53 (Figure 6) and knockdown of 
p53 with shRNA (Figure 7) attenuated the 
susceptibility of HEK293-OATP1B3 cells to 
microcystin-LR, suggesting that p53, at least 
in part, is associated with microcystin-LR–
induced apoptosis. p53 promotes apopto-
sis mediated by the mitochondrial pathway 
(Green and Kroemer 2009). However,   
caspase-3 is not involved in the apoptosis that 
occurs after exposure to microcystin-LR (Ding 
et al. 2002; Komatsu et al. 2007). Further 
studies are needed to clarify the contribution of 
p53 to cell fate determination after exposure of 
HEK293-OATP1B3 cells to microcystin-LR.
Conclusion
The present study has demon  strated that 
HEK293-OATP1B3 cells are a useful tool 
for analysis of the cellu  lar effects of low con-
centration of micro  cystin-LR. We revealed 
that the fate of HEK293-OATP1B3 cells is 
determined through activation of various cell 
signaling pathways, including MAPK path-
ways, especially the JNK pathway (Komatsu 
et al. 2007), as well as through Akt and p53 
signaling pathways. We have also shown 
the importance of p53 in microcystin-LR–
induced apoptosis (Figure 8). Our results 
suggest that conditions of inactivated p53, 
coupled with chronic exposure to low-dose 
microcystin-LR, may lead to cell proliferation 
through activation of Akt signaling. Results of 
this study may contribute to the development 
of chemoprevention and chemotherapeutic 
approaches to microcystin-LR poisoning.
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